Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Ibuprofen is generally considered safe for short-term relief of letrozole-related joint pain and stiffness, and turmeric or curcumin may help some people, but neither is risk-free and several factors matter. Ibuprofen and other NSAIDs can irritate the stomach, raise blood pressure, and strain the kidneys, especially with long-term daily use or when combined with other medications. Turmeric supplements may thin the blood, interact with chemotherapy or blood thinners, and are not tightly regulated for dose or purity. Acetaminophen, gentle movement, weight management, and switching aromatase inhibitors are other options worth discussing with your oncologist before you add anything new. There are important details and cautions to weigh, including when joint pain signals something more serious, so see below to understand more.
If aching joints, morning stiffness, or hand and knee pain are making daily life harder, it helps to know whether what you are feeling is a common medication side effect or something that needs a closer look. A free, instant, online symptom check can help you organize your symptoms, see possible causes, and walk into your next appointment with clear questions and better next steps.
Last reviewed for medical accuracy: 09/13/2026
Letrozole is a commonly prescribed aromatase inhibitor used to treat hormone-receptor-positive breast cancer in postmenopausal women. One of its most frequent side effects is joint pain (arthralgia), which can range from mild stiffness to significant discomfort that interferes with daily activities.
This guide explains what you need to know about using ibuprofen or turmeric to manage joint pain while on letrozole, based on credible sources. It also offers practical tips and reminds you to seek professional advice for any serious or life-threatening concerns.
• Letrozole works by blocking the enzyme aromatase, which reduces estrogen production.
• Estrogen plays a role in keeping joints and connective tissues healthy.
• Lower estrogen levels can lead to increased joint stiffness, pain, and inflammation.
• Up to 35–60% of women on letrozole report some degree of arthralgia.
Common symptoms include:
If joint pain is mild, lifestyle changes and over-the-counter remedies may help. For moderate to severe pain, speak to your healthcare provider about prescription options or adjustments to your treatment.
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) often used for mild to moderate pain relief.
Turmeric (Curcuma longa) contains curcumin, a natural compound with anti-inflammatory properties.
While ibuprofen and turmeric can help, combining them with other approaches often yields the best results:
While mild joint pain is common with letrozole, certain signs warrant prompt medical attention:
If you experience any of these, seek urgent care or call emergency services.
For ongoing symptoms that interfere with your quality of life, don’t hesitate to:
You might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance on your joint pain and other concerns.
Disclaimer: This information is for educational purposes and does not replace professional medical advice. If you have life-threatening or serious symptoms, seek immediate medical attention. Always speak to your doctor before making any changes to your treatment plan.
(References)
* Harbeck N, Haidinger R. The patient experience. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):91-103. doi: 10.1007/s10549-007-9703-8. Epub 2007 Oct 3. PMID: 17912639; PMCID: PMC2001217.
* Lee RJ, Armstrong AC, Wardley AM. Letrozole: advancing hormone therapy in breast cancer. Womens Health (Lond). 2012 Nov;8(6):611-8. doi: 10.2217/whe.12.49. PMID: 23181527.
* Hack CC, Häberle L, Brucker SY, Janni W, Volz B, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kuemmel S, Martin B, Thomssen C, Graf H, Wolf C, Lux MP, Bayer CM, Rauh C, Almstedt K, Gass P, Heindl F, Brodkorb T, Willer L, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Rack B, Beckmann MW, Fehm T, Rody A, Maass N, Hein A, Fasching PA, Nabieva N. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients. Breast. 2020 Apr;50:11-18. doi: 10.1016/j.breast.2019.12.017. Epub 2020 Jan 8. PMID: 31958661; PMCID: PMC7377331.
* Fong MK, Patel P. Aromatase Inhibitors. 2026 Jan. PMID: 32491779.
* Borrie AE, Rose FA, Choi YH, Perera FE, Read N, Sexton T, Lock M, Vandenberg TA, Hahn K, Younus J, Logan D, Potvin K, Yaremko B, Yu E, Lenehan J, Welch S, Teft WA, Kim RB. Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast Cancer Res Treat. 2020 Sep;183(2):365-372. doi: 10.1007/s10549-020-05777-1. Epub 2020 Jul 6. PMID: 32632513.
* Collin A, Vein J, Wittrant Y, Pereira B, Amode R, Guillet C, Richard D, Eschalier A, Balayssac D. A new clinically-relevant rat model of letrozole-induced chronic nociceptive disorders. Toxicol Appl Pharmacol. 2021 Aug 15;425:115600. doi: 10.1016/j.taap.2021.115600. Epub 2021 Jun 1. PMID: 34081940.
* Del Mastro L, Mansutti M, Bisagni G, Ponzone R, Durando A, Amaducci L, Campadelli E, Cognetti F, Frassoldati A, Michelotti A, Mura S, Urracci Y, Sanna G, Gori S, De Placido S, Garrone O, Fabi A, Barone C, Tamberi S, Bighin C, Puglisi F, Moretti G, Arpino G, Ballestrero A, Poggio F, Lambertini M, Montemurro F, Bruzzi P, Gruppo Italiano Mammella investigators. Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021 Oct;22(10):1458-1467. doi: 10.1016/S1470-2045(21)00352-1. Epub 2021 Sep 17. PMID: 34543613.
* Zheng L, Chen PF, Dai WC, Zheng ZQ, Wang HL. Curcumin Alleviates Hyperandrogenism and Promotes Follicular Proliferation in Polycystic Ovary Syndrome Rats: Insights on IRS1/PI3K/GLUT4 and PTEN Modulations. Chin J Integr Med. 2022 Dec;28(12):1088-1095. doi: 10.1007/s11655-022-3582-z. Epub 2022 Oct 15. PMID: 36327049.
* Baba O, Kisaoglu H, Kalyoncu M. Letrozole-induced inflammatory arthritis and tendinopathy in pediatric rheumatology setting. Int J Rheum Dis. 2023 Nov;26(11):2314-2316. doi: 10.1111/1756-185X.14748. Epub 2023 May 23. PMID: 37218595.
* Liang C, Zhang Y, An P, Zuo W, Zhang B. Safety profile of letrozole in the real world: a disproportionality analysis of FAERS database and systematic review of case reports. Expert Opin Drug Saf. 2025 Jul 9:1-11. doi: 10.1080/14740338.2025.2527964. Epub 2025 Jul 9. PMID: 40590361.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.